Clinical trial

A Study of KL590586 in Patients With Advanced Solid Tumors

NCT05265091

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2021-09-15

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2021-09-15Date precision: day

Registry last updated2026-05-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Advanced Solid Tumorunresolved

Interventions

KL590586 CapsuleDRUG

Sponsors & collaborators

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.lead sponsor

Mapped research locations

ChengduSichuan, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05265091 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.